NCT03157505View on ClinicalTrials.gov

Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis

PHASE3CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

January 5, 2014

Primary Completion Date

December 30, 2016

Study Completion Date

March 2, 2017

Conditions
Allergic RhinitisAllergic Reaction
Interventions
DRUG

Purethal Birch immunotherapy

Purethal birch was administered as perennial therapy: 24 months

OTHER

Placebo and symptomatic treatment

symptomatic treatment including: antihitamine drug, nasal dropps and placebo injection

All Listed Sponsors
lead

Medical University of Silesia

OTHER

NCT03157505 - Efficacy and Safety of Birch Pollen Immunotherapy in Local Allergic Rhinitis | Biotech Hunter | Biotech Hunter